DOTA-XYIMSR-01, CAS [[2051527-54-7]] Preis auf Anfrage

Produktübersicht

• Artikelname: DOTA-XYIMSR-01, CAS [[2051527-54-7]] Preis auf Anfrage
• Artikelnummer: MCE-HY-173116
• Hersteller Artikelnummer: HY-173116
• Alternativnummer: MCE-HY-173116-1UNIT
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

DOTA-XYIMSR-01 is a molecular probe targeting CAIX that can be labeled with 177Lu for the inhibition and localization of malignant gliomas. The uptake of [177Lu] Lu-XYIMSR-01 in U87MG tumors is 6.19 % of the injected dose per gram (% ID/g), and the tumor-to-muscle uptake ratio is 20.14. In the orthotopic glioma model, combined injection with Temozolomide (HY-17364) can significantly improve the survival rate of mice and inhibit tumor growth. DOTA-XYIMSR-01 shows promise for research in the field of anti-cancer therapy[1].

Produkteigenschaften

• Molekulargewicht: 1461.58
• CAS Nummer: [2051527-54-7]
• Formel: C61H88N16O22S2
• Target-Kategorie: Carbonic Anhydrase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound